Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter‐related infection treated with amikacin

Autor:	Katsunori Nakamura, Fusako Yonaha, Hideo Shiohira, Yoshitsugu Sunagawa, Sanae Kojya, Kentaro Kohagura, Yusuke Ohya, Nobuo Hokama, Shoji Tsuneyoshi
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	medicine.medical_treatment therapeutic drug monitoring lcsh:Medicine Case Report Case Reports 030204 cardiovascular system & hematology urologic and male genital diseases nontuberculous mycobacterium Peritoneal dialysis 03 medical and health sciences 0302 clinical medicine Pharmacokinetics amikacin medicine Dosing lcsh:R5-920 medicine.diagnostic_test business.industry lcsh:R Continuous ambulatory peritoneal dialysis General Medicine Catheter-Related Infections female genital diseases and pregnancy complications Nontuberculous mycobacterium peritoneal dialysis Amikacin Therapeutic drug monitoring 030220 oncology & carcinogenesis Anesthesia lcsh:Medicine (General) business medicine.drug
Zdroj:	Clinical Case Reports Clinical Case Reports, Vol 8, Iss 6, Pp 995-998 (2020)
ISSN:	2050-0904
Popis:	The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentrations in patients receiving CAPD.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a333f471ac5a9d1b30959b3d0695a4b http://europepmc.org/articles/PMC7303865 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.